AU2002312927A1 - Benzo(g)quinoxaline derivatives as effective compounds against infectious diseases - Google Patents
Benzo(g)quinoxaline derivatives as effective compounds against infectious diseasesInfo
- Publication number
- AU2002312927A1 AU2002312927A1 AU2002312927A AU2002312927A AU2002312927A1 AU 2002312927 A1 AU2002312927 A1 AU 2002312927A1 AU 2002312927 A AU2002312927 A AU 2002312927A AU 2002312927 A AU2002312927 A AU 2002312927A AU 2002312927 A1 AU2002312927 A1 AU 2002312927A1
- Authority
- AU
- Australia
- Prior art keywords
- benzo
- infectious diseases
- compounds against
- effective compounds
- against infectious
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
- C07D241/52—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01112289.2 | 2001-05-18 | ||
EP01112289 | 2001-05-18 | ||
US29232501P | 2001-05-22 | 2001-05-22 | |
US60/292,325 | 2001-05-22 | ||
US29890201P | 2001-06-19 | 2001-06-19 | |
US60/298,902 | 2001-06-19 | ||
EP01115508 | 2001-06-27 | ||
EP01115508.2 | 2001-06-27 | ||
PCT/EP2002/005573 WO2002094796A2 (en) | 2001-05-18 | 2002-05-21 | Benzo[g]quinoxaline derivatives as effective compounds against infectious diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002312927A1 true AU2002312927A1 (en) | 2002-12-03 |
Family
ID=27440128
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002312927A Abandoned AU2002312927A1 (en) | 2001-05-18 | 2002-05-21 | Benzo(g)quinoxaline derivatives as effective compounds against infectious diseases |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002312927A1 (en) |
WO (1) | WO2002094796A2 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002059321A2 (en) | 2001-01-23 | 2002-08-01 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa | Hepatitis c virus replicons and replicon enhanced cells |
WO2003086404A1 (en) * | 2002-04-08 | 2003-10-23 | Merck & Co., Inc. | Fused quinoxaline derivatives as inhibitors of akt activity |
US20090018149A1 (en) * | 2002-04-09 | 2009-01-15 | Andrea Missio | 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives and methods for medical intervention against mycobacterial infections |
JP4522862B2 (en) * | 2002-11-13 | 2010-08-11 | 株式会社半導体エネルギー研究所 | Quinoxaline derivatives, organic semiconductor devices and electroluminescent devices |
GB0328928D0 (en) * | 2003-12-12 | 2004-01-14 | Cancer Rec Tech Ltd | Materials and methods relating to cell cycle control |
WO2005065666A1 (en) * | 2003-12-22 | 2005-07-21 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Us of a pkc-delta inhibitor for the inhibition of metastatic melanoma |
DK2666481T3 (en) | 2003-12-26 | 2019-02-25 | Masatoshi Hagiwara | A method for regulating the phosphorylation of SR protein and antiviral agents comprising an SR protein activity regulator as the active ingredient |
EP1734999A2 (en) * | 2004-04-05 | 2006-12-27 | Myogen, Inc. | Inhibition of nuclear export as a treatment for cardiac hypertrophy and heart failure |
JP4835026B2 (en) * | 2005-04-15 | 2011-12-14 | 株式会社村田製作所 | Conductive composition containing compound having diphenylquinoxaline skeleton |
GB0608899D0 (en) * | 2006-05-05 | 2006-06-14 | Leuven K U Res & Dev | Novel viral replication inhibitors |
US8129390B2 (en) * | 2007-12-12 | 2012-03-06 | Rigel Pharmaceuticals, Inc. | Carboxamide, sulfonamide and amine compounds and methods for using the same |
JP5404607B2 (en) * | 2008-03-25 | 2014-02-05 | 株式会社キノファーマ | Aniline derivative having anti-RNA virus action |
WO2014100934A1 (en) * | 2012-12-24 | 2014-07-03 | Merck Sharp & Dohme Corp. | Glycosidase inhibitors and uses thereof |
WO2014165090A1 (en) * | 2013-03-13 | 2014-10-09 | The Broad Institute, Inc. | Compounds for the treatment of tuberculosis |
EP3322428B1 (en) * | 2015-07-15 | 2024-04-24 | Agency For Science, Technology And Research | Modulation of hepatitis b virus replication |
CN107556217B (en) * | 2017-09-15 | 2020-05-26 | 湖北鑫慧化工有限公司 | Production process of amino-K acid |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3145205A (en) * | 1962-12-10 | 1964-08-18 | American Home Prod | 6-benzoquinoxaline-carboxamides |
DE3346177A1 (en) * | 1983-12-21 | 1985-07-04 | Hoechst Ag, 6230 Frankfurt | NEW 2,3-BIS (ARYLETHENYL) -CHINOXALINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS PHOTO-CONDUCTIVE COMPOUNDS |
JPH0374372A (en) * | 1989-08-16 | 1991-03-28 | Terumo Corp | Pyrazine derivative and platelet agglutination inhibiting agent or antiinflammatory agent containing the same |
AU9318298A (en) * | 1997-11-14 | 1999-06-07 | Warner-Lambert Company | Small molecule intervention in hiv-1 replication |
-
2002
- 2002-05-21 WO PCT/EP2002/005573 patent/WO2002094796A2/en not_active Application Discontinuation
- 2002-05-21 AU AU2002312927A patent/AU2002312927A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002094796A3 (en) | 2003-12-04 |
WO2002094796A2 (en) | 2002-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002349297A1 (en) | Statin-like compounds | |
AU2002312927A1 (en) | Benzo(g)quinoxaline derivatives as effective compounds against infectious diseases | |
AU2002359165A1 (en) | Novel compounds | |
AU2002331707A1 (en) | Tetrahydroquinoline derivatives as antithrombotic agents | |
AU2002363600A1 (en) | Novel phenyl-propargylether derivatives | |
AUPR920301A0 (en) | Neurologically-active compounds | |
AU2002361987A1 (en) | Substituted beta-aminoalcohols used as medicaments | |
AU2002335154A1 (en) | Coumarin derivative | |
AU2002343546A1 (en) | Beta-carbolin derivatives as ptp-inhibitors | |
AU2002311321A1 (en) | Novel norstatin derivative | |
AU2002335529A1 (en) | Novel carbamoylpyrrolidone derivative | |
AU2002327384A1 (en) | Remedies for hepatitis c | |
AU2002355208A1 (en) | 4-oxoimidazolidine-2-spiropiperidine derivative | |
AU2002255269B8 (en) | 2-Iminopyrrolidine derivatives | |
AU2002358072A1 (en) | Isothiazolylaminocarbonyl derivatives as pesticides | |
AU2002248026A1 (en) | Novel adenine derivatives | |
AU2002349002A1 (en) | Substituted benzo(b)azepin-2-one compounds | |
AU2002346861A1 (en) | Substituted 1h-quinolin-2-one compounds | |
AUPR775701A0 (en) | New compounds | |
AU2002255414A1 (en) | New compounds | |
AUPR300701A0 (en) | New compounds | |
AU2002316006A1 (en) | New compounds | |
AUPR669701A0 (en) | New compounds | |
AU2002257943A1 (en) | Novel compounds for use as photoinitiators | |
AU2002219412A1 (en) | Fragrance compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |